JP2024529307A5 - - Google Patents
Info
- Publication number
- JP2024529307A5 JP2024529307A5 JP2024500469A JP2024500469A JP2024529307A5 JP 2024529307 A5 JP2024529307 A5 JP 2024529307A5 JP 2024500469 A JP2024500469 A JP 2024500469A JP 2024500469 A JP2024500469 A JP 2024500469A JP 2024529307 A5 JP2024529307 A5 JP 2024529307A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- acid
- conjugate according
- alkyl
- sifa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2109922.1 | 2021-07-09 | ||
| GBGB2109922.1A GB202109922D0 (en) | 2021-07-09 | 2021-07-09 | Radiotracers and therapeutics binding to fibroblast activation protein (fap) |
| PCT/US2022/073544 WO2023283627A1 (en) | 2021-07-09 | 2022-07-08 | Radiotracers and therapeutics binding to fibroblast activation protein (fap) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529307A JP2024529307A (ja) | 2024-08-06 |
| JP2024529307A5 true JP2024529307A5 (enExample) | 2025-06-11 |
Family
ID=77353994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500469A Pending JP2024529307A (ja) | 2021-07-09 | 2022-07-08 | 線維芽細胞活性化タンパク質（ｆａｐ）に結合する放射性トレーサーおよび治療薬 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240399001A1 (enExample) |
| EP (1) | EP4366786A1 (enExample) |
| JP (1) | JP2024529307A (enExample) |
| KR (1) | KR20240035488A (enExample) |
| CN (1) | CN117836013A (enExample) |
| GB (1) | GB202109922D0 (enExample) |
| WO (1) | WO2023283627A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024152775A1 (zh) * | 2023-01-17 | 2024-07-25 | 云合智药（苏州）生物科技有限公司 | 缀合物、配体单元及其用途 |
| WO2024227137A1 (en) * | 2023-04-28 | 2024-10-31 | The Board Of Regents Of The University Of Texas System | Structurally-reinforced stable theranostic copper radiopharmaceuticals targeting fibroblast activation protein for cancer diagnosis and therapy |
| WO2025106926A1 (en) * | 2023-11-16 | 2025-05-22 | Praxis Biotech LLC | Conjugates targeting fibroblast activation protein and uses thereof |
| WO2026041109A1 (zh) * | 2024-08-23 | 2026-02-26 | 苏州博锐创合医药有限公司 | 成纤维细胞活化蛋白抑制剂及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116474108A (zh) | 2016-12-14 | 2023-07-25 | 普渡研究基金会 | 成纤维细胞活化蛋白(fap)-靶向成像和治疗 |
| HUE070098T2 (hu) | 2017-07-28 | 2025-05-28 | Univ Muenchen Tech | Kettõs módusú radioaktív jelzõ és terapeutikumok |
| EA202090776A1 (ru) | 2017-10-23 | 2020-07-27 | Дзе Джонс Хопкинс Юниверсити | Визуализирующие и радиотерапевтические агенты, нацеленные на фибробласт-активирующий белок-альфа (fapalpha) |
| EP3749663A1 (en) | 2018-02-06 | 2020-12-16 | Universität Heidelberg | Fap inhibitor |
| CA3128406A1 (en) | 2019-01-30 | 2020-08-06 | Technische Universitat Munchen | Cancer diagnostic imaging agents |
| EA202191691A1 (ru) | 2019-01-30 | 2021-11-01 | Технише Универзитет Мюнхен | Радиоактивная метка, связывающая psma двумя способами, и терапевтическое средство |
| JP7801207B2 (ja) | 2019-07-08 | 2026-01-16 | ３ベー ファーマシューティカルズ ゲーエムベーハー | 線維芽細胞活性化タンパク質リガンドを含む化合物およびその使用 |
| FI3997103T3 (fi) | 2019-07-08 | 2025-02-03 | 3B Pharmaceuticals Gmbh | Fibroblastien aktivaatioproteiinin ligandia käsittäviä yhdisteitä ja niiden käyttö |
-
2021
- 2021-07-09 GB GBGB2109922.1A patent/GB202109922D0/en not_active Ceased
-
2022
- 2022-07-08 WO PCT/US2022/073544 patent/WO2023283627A1/en not_active Ceased
- 2022-07-08 US US18/577,580 patent/US20240399001A1/en active Pending
- 2022-07-08 KR KR1020247002851A patent/KR20240035488A/ko active Pending
- 2022-07-08 EP EP22777124.3A patent/EP4366786A1/en active Pending
- 2022-07-08 CN CN202280053524.XA patent/CN117836013A/zh active Pending
- 2022-07-08 JP JP2024500469A patent/JP2024529307A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024529307A5 (enExample) | ||
| JP2020528461A5 (enExample) | ||
| US12419976B2 (en) | Hybrid tracers for targeted cancer imaging and treatment | |
| JP7449864B2 (ja) | エバンスブルー誘導体の化学結合体ならびに前立腺癌を標的とするための放射線療法および造影剤としてのその使用 | |
| CN111285918B (zh) | 用于psma靶向的成像和放射疗法的金属/放射性金属标记的psma抑制物 | |
| CA2225453C (en) | Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis | |
| JP2024514528A5 (enExample) | ||
| BR112020001785A2 (pt) | radiotraçador e compostos radioterapêuticos bimodais | |
| JP2024536362A5 (enExample) | ||
| IL284963B1 (en) | Diagnostic imaging agents for cancer | |
| JP2022509220A5 (ja) | 腫瘍抗原標的化剤、医薬組成物、癌診断薬又は癌治療薬、ｉｎ ｖｉｔｒｏ法、及びその化合物 | |
| AU2016368542A1 (en) | Contrast agents | |
| US12427207B2 (en) | Pharmaceutical formulations | |
| JP2024529307A (ja) | 線維芽細胞活性化タンパク質（ｆａｐ）に結合する放射性トレーサーおよび治療薬 | |
| JP2018524352A (ja) | Ｈｂｅｄ−ビスホスホネート、その放射性金属コンジュゲート、およびセラノスティック剤としてのそれらの使用 | |
| JP2024505374A (ja) | デュアルモード放射性トレーサーおよびその療法 | |
| JP2024510267A5 (enExample) | ||
| IL305134A (en) | Dual mode radio and medical tracker | |
| CN121909051A (zh) | 靶向成纤维细胞活化蛋白的组合物及其使用方法 | |
| JP2024517971A5 (enExample) | ||
| EA050309B1 (ru) | Фармацевтические составы | |
| HK1248585A1 (en) | Hbed-bisphosphonates, radiometal conjugates thereof and their use as theranostic agents | |
| RU2020126278A (ru) | Ингибитор fap | |
| HK1248585B (zh) | Hbed-二膦酸盐/酯、其放射金属轭合物和它们作为治疗诊断剂的用途 | |
| JP2002506050A (ja) | 血清中で高い緩和性を有するマンガンキレート |